Blueshift Asset Management, LLC Athenex, Inc. Transaction History

Blueshift Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$1.36 - $2.94 $19,336 - $41,800	-14,218 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$2.97 - $4.84 $2,147 - $3,499	-723 Reduced 4.84%	14,218 $43,000
Q2 2021 Aug 13, 2021	BUY	$3.71 - $5.13 $3,450 - $4,770	930 Added 6.64%	14,941 $69,000
Q1 2021 May 06, 2021	BUY	$4.08 - $14.75 $9,902 - $35,798	2,427 Added 20.95%	14,011 $60,000
Q4 2020 Feb 12, 2021	BUY	$11.06 - $14.01 $128,119 - $162,291	11,584 New	11,584 $128,000
Q1 2020 May 14, 2020	SELL	$5.71 - $15.85 $89,207 - $247,624	-15,623 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$9.6 - $17.75 $149,980 - $277,308	15,623 New	15,623 $239,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.